ARandomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity).

Trial Profile

ARandomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity).

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2014

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 13 Feb 2013 New source identified and integrated (German Clinical Trials Register: DRKS00004129).
    • 09 Feb 2010 Additional trial locations (Canada, Switzerland) identified as reported by ClinicalTrials.gov.
    • 29 Dec 2009 Actual patient number changed from 612 to 397 as reported by clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top